Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.
Also called NCT01632371
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 252 participants
- Registry
-
NCT01632371
-
- Other papers using this trial's data
- Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01632371. Randomized; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2015-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4
- Acronym
- ISAR-DESIRE 4
- Condition
- Restenosis
- Condition
- Stable Angina Pectoris
- Condition
- Acute Coronary Syndrome
- Intervention (Device)
- Paclitaxel Eluting Balloon + Scoring Balloon
- Intervention (Device)
- Paclitaxel Eluting Balloon
- Lead sponsor
- Deutsches Herzzentrum Muenchen
- Collaborator
- Biotronik AG
Record details
- Record id
cardio:ct-nct01632371- Content hash
17fb233302350f2876a0d2e9d2af1727558c5a1aaf683aa5d5d69a31f64821e3